tm
Seeing Is Believing
tm
Seeing Is Believing
Akcea Therapeutics's activity chart (see below) currently has 28 price targets and 24 ratings on display.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 21.4 days.
Most recent stock forecast was given by from on 01-Sep-2020. First documented stock forecast 08-Aug-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Aug-2017
$30
6 years 1 months 22 days ago
(01-Sep-2020)
2/8 (25%)
$14.76 (96.85%)
30
Hold Since 25-Sep-2018
$20
$1.83 (10.07%)
$31
6 years 5 months 17 days ago
(06-May-2020)
1/2 (50%)
$4.76 (31.23%)
9
Hold Since 07-Oct-2019
$24
7 years 16 days ago
(07-Oct-2019)
3/4 (75%)
$5.96 (33.04%)
44
Buy Since 07-Oct-2019
$45
$26.83 (147.66%)
$45
7 years 16 days ago
(07-Oct-2019)
0/2 (0%)
$25.13 (126.47%)
Hold Since 07-Aug-2018
8 years 28 days ago
(25-Sep-2018)
3/3 (100%)
$-5.99 (-15.36%)
24
What is AKCA (Akcea Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on AKCA (Akcea Therapeutics)?
Which analyst has the most public recommendations on AKCA (Akcea Therapeutics)?
Which analyst is the currently most bullish on AKCA (Akcea Therapeutics)?
Which analyst is the currently most reserved on AKCA (Akcea Therapeutics)?
